Ketonal 100 Mg (Ketoprofen)

Ketoprofen works by non‑selectively inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. Lower prostaglandin levels lead to reduced inflammation, diminished pain signalling, and a modest antipyretic effect.

The appropriate dose of Ketonal 100 Mg is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and clinical response. Dosage may vary for different indications and routes of administration.

Ketoprofen’s safety in pregnancy and lactation is not well established. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and only under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ketonal (ketoprofen) offers a potency comparable to ibuprofen and naproxen but has a slightly longer half‑life, allowing less frequent dosing in some settings. Like other non‑selective NSAIDs, it shares similar gastrointestinal and renal risk profiles, so choice often depends on clinician preference, patient tolerance and specific therapeutic needs.

Ketonal 100 Mg should be stored below 25 °C in its original packaging, protected from light and moisture. Do not freeze the product. Handling should be performed by trained personnel using aseptic technique for intramuscular or intravenous administration.

Ketonal is given by a qualified healthcare professional as an intramuscular or intravenous injection. The route, injection site and rate of administration are selected according to the clinical indication and patient condition.

Serious adverse events include gastrointestinal bleeding or ulcer perforation, acute renal failure, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, and hepatic failure. Patients should be monitored for signs of bleeding, renal dysfunction, rash or respiratory distress, and treatment should be stopped immediately if these occur.

Ketonal should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, active peptic ulcer disease, severe renal or hepatic impairment, uncontrolled heart failure, and in patients receiving anticoagulant therapy unless closely monitored. It is also contraindicated in the third trimester of pregnancy.